These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
551 related articles for article (PubMed ID: 28598982)
1. α-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2. Kim HM; Kim YM; Huh JH; Lee ES; Kwon MH; Lee BR; Ko HJ; Chung CH PLoS One; 2017; 12(6):e0179204. PubMed ID: 28598982 [TBL] [Abstract][Full Text] [Related]
2. Long-term dietary supplementation with low-dose nobiletin ameliorates hepatic steatosis, insulin resistance, and inflammation without altering fat mass in diet-induced obesity. Kim YJ; Choi MS; Woo JT; Jeong MJ; Kim SR; Jung UJ Mol Nutr Food Res; 2017 Aug; 61(8):. PubMed ID: 28116779 [TBL] [Abstract][Full Text] [Related]
3. Attenuation by Tetrahydrocurcumin of Adiposity and Hepatic Steatosis in Mice with High-Fat-Diet-Induced Obesity. Pan MH; Chen JW; Kong ZL; Wu JC; Ho CT; Lai CS J Agric Food Chem; 2018 Dec; 66(48):12685-12695. PubMed ID: 30415544 [TBL] [Abstract][Full Text] [Related]
4. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes. Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944 [TBL] [Abstract][Full Text] [Related]
5. Glucoraphanin Ameliorates Obesity and Insulin Resistance Through Adipose Tissue Browning and Reduction of Metabolic Endotoxemia in Mice. Nagata N; Xu L; Kohno S; Ushida Y; Aoki Y; Umeda R; Fuke N; Zhuge F; Ni Y; Nagashimada M; Takahashi C; Suganuma H; Kaneko S; Ota T Diabetes; 2017 May; 66(5):1222-1236. PubMed ID: 28209760 [TBL] [Abstract][Full Text] [Related]
6. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice. Liu LF; Purushotham A; Wendel AA; Belury MA Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064 [TBL] [Abstract][Full Text] [Related]
7. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation. Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380 [TBL] [Abstract][Full Text] [Related]
8. Curcumin analog CUR5-8 ameliorates nonalcoholic fatty liver disease in mice with high-fat diet-induced obesity. Lee ES; Kwon MH; Kim HM; Woo HB; Ahn CM; Chung CH Metabolism; 2020 Feb; 103():154015. PubMed ID: 31758951 [TBL] [Abstract][Full Text] [Related]
9. The CCR2 Inhibitor Propagermanium Attenuates Diet-Induced Insulin Resistance, Adipose Tissue Inflammation and Non-Alcoholic Steatohepatitis. Mulder P; van den Hoek AM; Kleemann R PLoS One; 2017; 12(1):e0169740. PubMed ID: 28076416 [TBL] [Abstract][Full Text] [Related]
10. Tongqiaohuoxue decoction ameliorates obesity-induced inflammation and the prothrombotic state by regulating adiponectin and plasminogen activator inhibitor-1. Kim SH; Park HS; Hong MJ; Yoo JY; Lee H; Lee JA; Hur J; Kwon DY; Kim MS J Ethnopharmacol; 2016 Nov; 192():201-209. PubMed ID: 27404230 [TBL] [Abstract][Full Text] [Related]
12. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation. Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011 [TBL] [Abstract][Full Text] [Related]
13. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders. Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050 [TBL] [Abstract][Full Text] [Related]
14. Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice. Park HS; Hur HJ; Kim SH; Park SJ; Hong MJ; Sung MJ; Kwon DY; Kim MS Mol Nutr Food Res; 2016 Sep; 60(9):1944-55. PubMed ID: 27145114 [TBL] [Abstract][Full Text] [Related]
15. Melatonin improves non-alcoholic fatty liver disease via MAPK-JNK/P38 signaling in high-fat-diet-induced obese mice. Sun H; Wang X; Chen J; Song K; Gusdon AM; Li L; Bu L; Qu S Lipids Health Dis; 2016 Nov; 15(1):202. PubMed ID: 27876064 [TBL] [Abstract][Full Text] [Related]
16. Ugonin J improves metabolic disorder and ameliorates nonalcoholic fatty liver disease by regulating the AMPK/AKT signaling pathway. Chang TC; Chiou WC; Lai WH; Huang HC; Huang YL; Liu HK; Liang YC; Huang C Pharmacol Res; 2021 Jan; 163():105298. PubMed ID: 33220422 [TBL] [Abstract][Full Text] [Related]
18. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice. Cai X; Fang C; Hayashi S; Hao S; Zhao M; Tsutsui H; Nishiguchi S; Sheng J J Gastroenterol; 2016 Aug; 51(8):819-29. PubMed ID: 26794005 [TBL] [Abstract][Full Text] [Related]
19. Salicornia Extract Ameliorates Salt-Induced Aggravation of Nonalcoholic Fatty Liver Disease in Obese Mice Fed a High-Fat Diet. Kim JH; Suk S; Jang WJ; Lee CH; Kim JE; Park JK; Kweon MH; Kim JH; Lee KW J Food Sci; 2017 Jul; 82(7):1765-1774. PubMed ID: 28608557 [TBL] [Abstract][Full Text] [Related]
20. SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice. Xu L; Nagata N; Nagashimada M; Zhuge F; Ni Y; Chen G; Mayoux E; Kaneko S; Ota T EBioMedicine; 2017 Jun; 20():137-149. PubMed ID: 28579299 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]